版本:
中国

BRIEF-Global Blood reports publication of preclinical results supporting GBT440 program

Sept 14 Global Blood Therapeutics :

* Global Blood Therapeutics announces publication of preclinical results supporting GBT440 program for Hypoxemic Pulmonary disorders

* Recently initiated a phase 2A trial of GBT440 in IPF patients and anticipate data from this trial in second half of 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐